Related Experiment Video
Updated: Apr 11, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Posttranslational modifications of α-tubulin in alzheimer disease
Fan Zhang1,2, Bo Su3, Chunyu Wang1,4
1Department of Pathology, Case Western Reserve University, Cleveland, OH 44121 USA.
Background:
In Alzheimer disease (AD), hyperphosphorylation of tau proteins results in microtubule destabilization and cytoskeletal abnormalities. Our prior ultra-morphometric studies documented a clear reduction in microtubules in pyramidal neurons in AD compared to controls, however, this reduction did not coincide with the presence of paired helical filaments. The latter suggests the presence of compensatory mechanism(s) that stabilize microtubule dynamics despite the loss of tau binding and stabilization. Microtubules are composed of tubulin dimers which are subject to posttranslational modifications that affect the stability and function of microtubules.
Methods:
In this study, we performed a detailed analysis on changes in the posttranslational modifications in tubulin in postmortem human brain tissues from AD patients and age-matched controls by immunoblot and immunocytochemistry.
Results:
Consistent with our previous study, we found decreased levels of α-tubulin in AD brain. Levels of tubulin with various posttranslational modifications such as polyglutamylation, tyrosination, and detyrosination were also proportionally reduced in AD brain, but, interestingly, there was an increase in the proportion of the acetylated α-tubulin in the remaining α-tubulin. Tubulin distribution was changed from predominantly in the processes to be more accumulated in the cell body. The number of processes containing polyglutamylated tubulin was well preserved in AD neurons. While there was a cell autonomous detrimental effect of NFTs on tubulin, this is likely a gradual and slow process, and there was no selective loss of acetylated or polyglutamylated tubulin in NFT-bearing neurons.
Conclusions:
Overall, we suggest that the specific changes in tubulin modification in AD brain likely represent a compensatory response.
Insights
Alzheimer disease (AD) brains show altered tubulin modifications, with increased acetylation suggesting a compensatory mechanism to stabilize microtubules despite tau pathology. This research offers insights into AD
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer disease (AD) is characterized by tau hyperphosphorylation, leading to microtubule destabilization and cytoskeletal abnormalities.
- Previous studies noted reduced microtubules in AD neurons, but without concurrent paired helical filaments, suggesting compensatory mechanisms.
- Microtubule stability and function are influenced by posttranslational modifications of tubulin dimers.
Purpose of the Study:
- To investigate changes in posttranslational modifications of tubulin in postmortem human brain tissues from AD patients and controls.
- To analyze the impact of these modifications on microtubule stability in the context of Alzheimer disease.
Main Methods:
- Utilized immunoblot and immunocytochemistry techniques for detailed analysis of tubulin posttranslational modifications.
- Examined postmortem human brain tissues from individuals with Alzheimer disease and age-matched controls.
Main Results:
- Observed decreased levels of alpha-tubulin (α-tubulin) in AD brain tissue.
- Found proportional reductions in polyglutamylation, tyrosination, and detyrosination of tubulin in AD.
- Noted an increased proportion of acetylated α-tubulin relative to total α-tubulin in AD brains, with altered tubulin distribution.
Conclusions:
- The specific alterations in tubulin modifications in AD brains are proposed to be a compensatory response.
- These modifications may play a role in stabilizing microtubule dynamics despite tau pathology and neurofibrillary tangle formation.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

